Douglas E. Onsi - Jan 29, 2024 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
CEO,CFO,Pres.,GC,Treas.,&Sec., Director
Signature
/s/ Douglas E. Onsi
Stock symbol
LPTX
Transactions as of
Jan 29, 2024
Transactions value $
$0
Form type
4
Date filed
1/31/2024, 09:32 PM
Previous filing
Jan 30, 2024
Next filing
Oct 4, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Employee Stock Option (Right to Buy) Award $0 +170K $0.00 170K Jan 29, 2024 Common Stock 170K $2.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of January 29, 2024.